Listed

PTC Therapeutics, Inc.

PTCTNasdaqCIK 1070081HealthcareFiscal year ends Dec 31

Reports and events: 261 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

PTC Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2024-04-2616:30 ETDEF 14AProxy statementPeriod 2024-06-180001558370-24-005924
2024-04-2516:36 ET10-QQuarterly reportPeriod 2024-03-310001558370-24-005782
2024-04-2516:10 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-24-005767
2024-02-2916:36 ET10-KAnnual reportPeriod 2023-12-310001558370-24-002196
2024-02-2916:15 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-24-002189
2024-01-2516:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-24-000006
2024-01-0809:27 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-24-000003
2023-10-2616:34 ET10-QQuarterly reportPeriod 2023-09-300001070081-23-000065
2023-10-2616:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-23-000063
2023-10-1916:15 ET8-K1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001070081-23-000059
2023-10-1908:03 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001070081-23-000056
2023-09-2816:45 ET8-K2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-23-000053
2023-09-2209:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-103032
2023-09-1506:15 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001558370-23-015770
2023-08-0316:34 ET10-QQuarterly reportPeriod 2023-06-300001070081-23-000050
2023-08-0316:03 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-23-000048
2023-07-1912:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001070081-23-000043
2023-07-1716:46 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001070081-23-000040
2023-06-2107:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-23-000036
2023-06-1516:41 ETSC 13D/AOwnership report, active investor, amended0001104659-23-071641
2023-06-0616:04 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001070081-23-000033
2023-05-2317:17 ET8-K2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-063688
2023-05-1707:04 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001070081-23-000030
2023-04-2716:35 ET10-QQuarterly reportPeriod 2023-03-310001070081-23-000028
2023-04-2716:02 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-23-000026
2023-04-2608:22 ETDEF 14AProxy statement0001070081-23-000020
2023-04-1817:11 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001070081-23-000015
2023-03-2407:45 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-23-036263
2023-03-0816:16 ET10-K/AAnnual report, amendedPeriod 2022-12-310001104659-23-030113
2023-02-2116:50 ET10-KAnnual reportPeriod 2022-12-310001070081-23-000011
2023-02-2116:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-23-000008
2023-01-0909:23 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-23-000004
2022-12-0616:15 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-22-124889
2022-10-2716:38 ET10-QQuarterly reportPeriod 2022-09-300001070081-22-000041
2022-10-2716:12 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-22-000038
2022-10-2716:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-22-112002
2022-10-1816:27 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-22-000035
2022-09-0707:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-22-014219
2022-08-1517:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001558370-22-013641
2022-08-0416:35 ET10-QQuarterly reportPeriod 2022-06-300001070081-22-000031
2022-08-0416:04 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-22-000029
2022-06-2108:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-22-010112
2022-06-0909:15 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-22-009860
2022-05-2716:12 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001070081-22-000020
2022-05-0316:36 ET10-QQuarterly reportPeriod 2022-03-310001070081-22-000017
2022-05-0316:02 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-22-000015
2022-04-2816:15 ETDEF 14AProxy statementPeriod 2022-06-080001558370-22-006288
2022-02-2216:36 ET10-KAnnual reportPeriod 2021-12-310001070081-22-000011
2022-02-2216:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001070081-22-000009
2022-01-1007:21 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-22-000153

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 17:24 ET. Listed shows no prices and gives no investment advice.